 | | | | |
| |  | |  | | |
| |
 |
| PRIME NEWS | |
|
 |
|
|
The South Korea pharmaceuticals market is expected to stabilize from 2010, showing slight deceleration in growth over the years up to 2014, according to a new report from Research and Markets
|
|
|
|
|
|
|
|
|
Medivir AB, Sweden announced it has appointed South Korea's Daewoong Pharmaceutical as its exclusive distributor for Xerclear in South Korea
|
|
|
|
|
|
|
| | | 
BioSpectrum Korea brings to you the latest news and information on Korea medical technology, Korea biotech industry, Korea medical devices and Korean pharmaceutical trends.
| | | | |  | |  | | |
|
|
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
Elekta opens facility in S Korea for cancer management
|
|
| South Korea, the worlds 15th largest economy, is among the leaders in Asia Pacific and the site of Elektas (a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders) new office.
|
|
|
|
|
|
Boryung Pharma relies on Cegedim Dendrites CRM solution
|
|
| Cegedim Dendrite , a leading provider of Life Sciences-specific customer relationship management (CRM) solutions, announced that Boryung Pharmaceutical, has implemented Cegedim Dendrites Mobile Intelligence CRM solution |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
Draeger Medical appoints GM for Korea operations
|
|
| Draeger, a Germany-based company with over 120 years of experiences in medical and safety technology, announced that it has appointed Mr Kim Byung-do as the General Manager of Draeger Medical Korea |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
OvPlex: S Korea study begins for KFDA approval
|
|
| HealthLinx has finalized research agreements with its collaborators in South Korea to begin the 220 patient study required for South Korea Food and Drug Administration (KFDA) approval for the distribution of OvPlex. |
|
|
|
|
|
Neurotech to initiate phase I clinical testing of AAD-2004
|
|
| Neurotech Pharmaceuticals, has begun dosing in the phase I clinical testing of AAD-2004 which is drug to remove free radicals and PGE2, the mediators of nerve injury in Alzheimer's disease, Parkinson's, and amyotrophic lateral sclerosis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
|
|
Green Cross gets KFDA approvals for peramivir
|
|
| Green Cross Corporation has received marketing and manufacturing approval from KFDA for intravenous (i.v.) peramivir to treat patients with influenza A & B viruses, including pandemic H1N1 and avian influenza. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
|
|
Rank 17: Dong-A joins biopharma bandwagon
|
|
| The BioSpectrum Asia Pacific Survey 2010 gives a rounded view of the progress the life sciences industry has made. Dong-A has made a firm commitment to biopharmaceutical research as the market for biopharma is growing rapidly.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
